After Myriad: Genetic Testing in the Wake of Recent Supreme Court Decisions about Gene Patents

Genetic testing is becoming more common and more powerful by the day. The costs of the underlying DNA sequencing technology are plummeting, making it likely that tests based on it will become even more pervasive. The use of tests to determine DNA sequence to help make clinical decisions is here to s...

Descripción completa

Detalles Bibliográficos
Autores principales: Cook-Deegan, Robert, Niehaus, Annie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Ethics in Medical Genetics (LS Parker, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225052/
https://www.ncbi.nlm.nih.gov/pubmed/25401053
http://dx.doi.org/10.1007/s40142-014-0055-5
_version_ 1782343449078398976
author Cook-Deegan, Robert
Niehaus, Annie
author_facet Cook-Deegan, Robert
Niehaus, Annie
author_sort Cook-Deegan, Robert
collection PubMed
description Genetic testing is becoming more common and more powerful by the day. The costs of the underlying DNA sequencing technology are plummeting, making it likely that tests based on it will become even more pervasive. The use of tests to determine DNA sequence to help make clinical decisions is here to stay. DNA sequencing is also finding new uses in forensics, determination of ancestry, understanding the history and genetic lineages of human populations and many other applications.
format Online
Article
Text
id pubmed-4225052
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-42250522014-11-13 After Myriad: Genetic Testing in the Wake of Recent Supreme Court Decisions about Gene Patents Cook-Deegan, Robert Niehaus, Annie Curr Genet Med Rep Ethics in Medical Genetics (LS Parker, Section Editor) Genetic testing is becoming more common and more powerful by the day. The costs of the underlying DNA sequencing technology are plummeting, making it likely that tests based on it will become even more pervasive. The use of tests to determine DNA sequence to help make clinical decisions is here to stay. DNA sequencing is also finding new uses in forensics, determination of ancestry, understanding the history and genetic lineages of human populations and many other applications. Springer US 2014-09-11 2014 /pmc/articles/PMC4225052/ /pubmed/25401053 http://dx.doi.org/10.1007/s40142-014-0055-5 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Ethics in Medical Genetics (LS Parker, Section Editor)
Cook-Deegan, Robert
Niehaus, Annie
After Myriad: Genetic Testing in the Wake of Recent Supreme Court Decisions about Gene Patents
title After Myriad: Genetic Testing in the Wake of Recent Supreme Court Decisions about Gene Patents
title_full After Myriad: Genetic Testing in the Wake of Recent Supreme Court Decisions about Gene Patents
title_fullStr After Myriad: Genetic Testing in the Wake of Recent Supreme Court Decisions about Gene Patents
title_full_unstemmed After Myriad: Genetic Testing in the Wake of Recent Supreme Court Decisions about Gene Patents
title_short After Myriad: Genetic Testing in the Wake of Recent Supreme Court Decisions about Gene Patents
title_sort after myriad: genetic testing in the wake of recent supreme court decisions about gene patents
topic Ethics in Medical Genetics (LS Parker, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225052/
https://www.ncbi.nlm.nih.gov/pubmed/25401053
http://dx.doi.org/10.1007/s40142-014-0055-5
work_keys_str_mv AT cookdeeganrobert aftermyriadgenetictestinginthewakeofrecentsupremecourtdecisionsaboutgenepatents
AT niehausannie aftermyriadgenetictestinginthewakeofrecentsupremecourtdecisionsaboutgenepatents

Ejemplares similares